IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MAZZIOTTI, Gherardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.360
AS - Asia 2.005
EU - Europa 1.888
SA - Sud America 360
Continente sconosciuto - Info sul continente non disponibili 76
AF - Africa 49
OC - Oceania 6
Totale 9.744
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.240
SG - Singapore 735
CN - Cina 722
UA - Ucraina 427
PL - Polonia 364
BR - Brasile 304
DE - Germania 273
HK - Hong Kong 187
FI - Finlandia 168
IT - Italia 138
FR - Francia 137
GB - Regno Unito 134
VN - Vietnam 90
RU - Federazione Russa 78
TR - Turchia 68
CA - Canada 67
IN - India 66
IE - Irlanda 65
BD - Bangladesh 47
AR - Argentina 23
MX - Messico 21
CZ - Repubblica Ceca 19
ZA - Sudafrica 19
SE - Svezia 18
ES - Italia 14
IQ - Iraq 13
BE - Belgio 12
NL - Olanda 12
ID - Indonesia 11
JP - Giappone 10
VE - Venezuela 9
NG - Nigeria 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
EU - Europa 7
JM - Giamaica 7
CL - Cile 6
CR - Costa Rica 6
IR - Iran 6
KR - Corea 6
MA - Marocco 6
AU - Australia 5
CO - Colombia 5
KE - Kenya 5
PE - Perù 5
TT - Trinidad e Tobago 5
AL - Albania 4
AT - Austria 4
PK - Pakistan 4
RO - Romania 4
EC - Ecuador 3
EE - Estonia 3
NP - Nepal 3
AM - Armenia 2
BO - Bolivia 2
CH - Svizzera 2
DZ - Algeria 2
EG - Egitto 2
GE - Georgia 2
GT - Guatemala 2
IL - Israele 2
JO - Giordania 2
KW - Kuwait 2
LT - Lituania 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CM - Camerun 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GP - Guadalupe 1
HN - Honduras 1
HT - Haiti 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NR - Nauru 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TG - Togo 1
Totale 9.674
Salva come PNG Salva come JPEG
Città #
Fairfield 644
Ashburn 595
Singapore 387
Warsaw 358
Houston 342
Woodbridge 317
Jacksonville 290
San Jose 271
Seattle 248
Cambridge 234
Ann Arbor 215
Wilmington 199
Beijing 195
Hong Kong 187
The Dalles 133
Council Bluffs 131
Chandler 124
Princeton 118
Nanjing 103
New York 99
Helsinki 96
Los Angeles 81
Dublin 64
Lauterbourg 59
Istanbul 57
Dallas 51
Nanchang 51
Munich 48
Columbus 45
Moscow 38
Des Moines 36
San Diego 34
Santa Clara 31
Shenyang 31
São Paulo 30
Brescia 29
Shanghai 28
Chicago 27
Buffalo 26
San Francisco 25
Ho Chi Minh City 23
Orem 23
Redondo Beach 22
Milan 21
Toronto 21
Changsha 20
Jiaxing 20
Tianjin 20
Washington 20
Atlanta 18
London 18
Mumbai 17
Boardman 16
Hanoi 16
Hebei 16
Manchester 16
Denver 15
Rio de Janeiro 15
Brno 14
Poplar 14
Turku 14
Dong Ket 12
Kunming 12
Montreal 12
Phoenix 12
Brooklyn 11
Hangzhou 11
Brussels 10
Charlotte 10
Tokyo 10
Augusta 9
Chennai 9
Philadelphia 9
San Mateo 9
Abuja 8
Brasília 8
Dhaka 8
Johannesburg 8
Mexico City 8
Stockholm 8
Ankara 7
Belo Horizonte 7
Cassina de' Pecchi 7
Lancaster 7
Baghdad 6
Boston 6
Curitiba 6
Greifswald 6
Jakarta 6
Kingston 6
Leawood 6
North Bergen 6
Paris 6
Tashkent 6
Vancouver 6
Bari 5
Frankfurt am Main 5
Jinan 5
Lappeenranta 5
Monmouth Junction 5
Totale 6.759
Salva come PNG Salva come JPEG
Nome #
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 383
Elevated intraocular pressure in patients with acromegaly 350
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 202
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 202
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 195
Growth hormone deficiency in treated acromegaly 188
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 182
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 173
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 167
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 164
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 160
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 159
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 158
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 156
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 154
Cardiovascular risk in aging and obesity: is there a role for GH. 154
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 151
Growth hormone deficiency in the adult. 150
New understanding and treatments for osteoporosis. 149
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 147
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 146
Prevalence of vertebral fractures in men with acromegaly 145
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 145
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects. 143
Octreotide for acromegaly treatment: a reappraisal. 143
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 143
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 141
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. 140
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 140
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 139
Active acromegaly enhances spontaneous parathyroid hormone pulsatility. 137
Glucocorticoids and the regulation of growth hormone secretion. 136
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 134
Cushing's syndrome and bone. 130
Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. 129
Glucocorticoid-induced osteoporosis: pathophysiology and therapy. 127
GH deficiency in the adult and bone. 127
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 127
High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. 126
Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome 126
Osteoporosis in HIV patients: an emerging clinical issue 125
Commentary:Postsurgical monitoring of acromegaly 123
Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects. 122
Glucocorticoid-induced osteoporosis: an update. 121
Treatment with metformin is protective against limitations in instrumental activities of daily living in older subjects with type 2 diabetes mellitus. 121
Vertebral fractures in males with prolactinoma. 121
High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma 120
Growth hormone, insulin like growth factors, and the skeleton 120
Subclinical thyrotoxicosis and bone 120
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. 119
Growth hormone replacement therapy and fracture risk 119
Diagnosis and treatment of acromegaly and its complications: consensus guidelines. 117
Pituitary diseases and bone 117
Resistance to somatostatin analogs in acromegaly: an evolving concept? 116
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 116
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA. 115
Prevention and treatment of glucocorticoid-induced osteoporosis. 115
Meta-analysis on the effects of octreotide on tumor mass in acromegaly. 114
Molecular imaging in acromegaly: should clinicians look carefully at developments in the field? 114
Drug-induced osteoporosis:mechanism and clinical implications 111
Glucocorticoid-induced osteoporosis and parathyroid hormone. 111
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 111
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 109
Glucocorticoid replancement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 98
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 91
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 90
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 88
Growth Hormone Insuline like Growth Factor-1, and the Kidney Pathophysiological and Clinical Implication 82
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 68
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 49
null 13
Totale 9.744
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.113
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022353 0 0 0 15 5 25 26 32 23 54 39 134
2022/2023401 69 2 2 22 48 119 1 32 66 2 16 22
2023/2024584 28 14 42 54 42 114 26 17 136 6 6 99
2024/20251.109 6 3 12 156 135 91 58 51 144 43 268 142
2025/20262.350 261 297 144 261 324 175 389 53 140 149 127 30
2026/2027634 81 95 150 308 0 0 0 0 0 0 0 0
Totale 9.744